Form D — Savannah Therapeutics, Inc
0002149298-26-000001 · filed Sep 11, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Other Health Care filings
Offering
- Industry
- Other Health Care
- Exemptions
- 06b
- Reported offering amount
- $6,000,000
- Reported amount sold
- $3,855,000
- Minimum investment
- $25,000
- Investors
- 28
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Savannah Therapeutics, Inc
- CIK
- 2149298
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2026
- Address
- 5650 Rivertech Court
Riverdale, MD 20737 - Phone
- 6514910507
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Thomas Wollan · Executive OfficerEdina, MN Find on LinkedIn ↗
-
Matthew Dowling · DirectorBaltimore, MD Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗